{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:32:21Z","timestamp":1794958341060,"version":"4.9.1"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T00:00:00Z","timestamp":1728172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T00:00:00Z","timestamp":1728172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-024-05975-0","type":"journal-article","created":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T15:01:23Z","timestamp":1728226883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Research progress on prognostic factors of gallbladder carcinoma"],"prefix":"10.1007","volume":"150","author":[{"given":"Wentao","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,6]]},"reference":[{"key":"5975_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3892\/or.2012.2180","volume":"29","author":"A Affolter","year":"2013","unstructured":"Affolter A, Schmidtmann I, Mann WJ, Brieger J (2013) Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment. Oncol Rep 29:785\u2013790. https:\/\/doi.org\/10.3892\/or.2012.2180","journal-title":"Oncol Rep"},{"key":"5975_CR2","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","volume":"69","author":"S Altenh\u00f6fer","year":"2012","unstructured":"Altenh\u00f6fer S et al (2012) The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69:2327\u20132343. https:\/\/doi.org\/10.1007\/s00018-012-1010-9","journal-title":"Cell Mol Life Sci"},{"key":"5975_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA: Cancer J Clin 67:93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA: Cancer J Clin"},{"key":"5975_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0039-6060(99)70208-4","volume":"125","author":"Y Aoki","year":"1999","unstructured":"Aoki Y, Shimura H, Li H, Mizumoto K, Date K, Tanaka M (1999) A model of port-site metastases of gallbladder cancer: the influence of peritoneal injury and its repair on abdominal wall metastases. Surgery 125:553\u2013559","journal-title":"Surgery"},{"key":"5975_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1634\/theoncologist.2018-0044","volume":"23","author":"H-T Arkenau","year":"2018","unstructured":"Arkenau H-T et al (2018) ramucirumab plus pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: nonrandomized, open-label, phase I trial (JVDF). Oncologist 23:1407-e1136. https:\/\/doi.org\/10.1634\/theoncologist.2018-0044","journal-title":"Oncologist"},{"key":"5975_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.bcp.2008.11.009","volume":"77","author":"G Bartosz","year":"2009","unstructured":"Bartosz G (2009) Reactive oxygen species: destroyers or messengers? Biochem Pharmacol 77:1303\u20131315. https:\/\/doi.org\/10.1016\/j.bcp.2008.11.009","journal-title":"Biochem Pharmacol"},{"key":"5975_CR7","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","volume":"28","author":"F Bozzetti","year":"2017","unstructured":"Bozzetti F (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol 28:2107\u20132118. https:\/\/doi.org\/10.1093\/annonc\/mdx271","journal-title":"Ann Oncol"},{"key":"5975_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-016-0346-7","volume":"35","author":"Y Cao","year":"2016","unstructured":"Cao Y et al (2016) Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. J Exp Clin Cancer Res 35:68. https:\/\/doi.org\/10.1186\/s13046-016-0346-7","journal-title":"J Exp Clin Cancer Res"},{"key":"5975_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3760\/cma.j.cn112139-20231218-00284","volume":"62","author":"C Chen","year":"2024","unstructured":"Chen C, Zhang D, Li Q, Lei JJ, Geng ZM (2024) The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients. Zhonghua Wai Ke Za Zhi 62:302\u2013308. https:\/\/doi.org\/10.3760\/cma.j.cn112139-20231218-00284","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"5975_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2016.04.034","volume":"8","author":"KR Chng","year":"2016","unstructured":"Chng KR et al (2016) Tissue microbiome profiling identifies an enrichment of specific enteric bacteria in opisthorchis viverrini associated cholangiocarcinoma. EBioMedicine 8:195\u2013202. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.034","journal-title":"EBioMedicine"},{"key":"5975_CR11","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.18632\/oncotarget.13731","volume":"8","author":"K-M Cho","year":"2017","unstructured":"Cho K-M et al (2017) Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer. Oncotarget 8:2329\u20132341. https:\/\/doi.org\/10.18632\/oncotarget.13731","journal-title":"Oncotarget"},{"key":"5975_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.21037\/atm.2020.03.182","volume":"8","author":"YH Choi","year":"2020","unstructured":"Choi YH, Lee SH (2020) Editorial on \u201cA new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery.\u201d Ann Transl Med. 8:522. https:\/\/doi.org\/10.21037\/atm.2020.03.182","journal-title":"Ann Transl Med."},{"key":"5975_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1158\/1055-9965.EPI-18-1066","volume":"28","author":"YH Choi","year":"2019","unstructured":"Choi YH et al (2019) A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with advanced gallbladder cancer receiving chemotherapy. Cancer Epidemiol Biomarkers Prev 28:1045\u20131051. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-1066","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5975_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.hpb.2022.06.008","volume":"24","author":"G Cotter","year":"2022","unstructured":"Cotter G et al (2022) Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis. HPB (Oxford) 24:1980\u20131988. https:\/\/doi.org\/10.1016\/j.hpb.2022.06.008","journal-title":"HPB (Oxford)"},{"key":"5975_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004235","author":"EJ Davis","year":"2022","unstructured":"Davis EJ et al (2022) First-in-human phase I\/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004235","journal-title":"J Immunother Cancer"},{"key":"5975_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00268-004-6886-6","volume":"28","author":"XA de Aretxabala","year":"2004","unstructured":"de Aretxabala XA et al (2004) Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer. World J Surg 28:544\u2013547","journal-title":"World J Surg"},{"key":"5975_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/13543784.2021.1928636","volume":"30","author":"S De Lorenzo","year":"2021","unstructured":"De Lorenzo S, Garajova I, Stefanini B, Tovoli F (2021) Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development. Expert Opin Investig Drugs 30:759\u2013772. https:\/\/doi.org\/10.1080\/13543784.2021.1928636","journal-title":"Expert Opin Investig Drugs"},{"key":"5975_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s13277-014-2606-5","volume":"36","author":"Q Ding","year":"2015","unstructured":"Ding Q et al (2015) CLIC1 overexpression is associated with poor prognosis in gallbladder cancer. Tumour Biol 36:193\u2013198. https:\/\/doi.org\/10.1007\/s13277-014-2606-5","journal-title":"Tumour Biol"},{"key":"5975_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3760\/cma.j.cn112139-20210226-00099","volume":"60","author":"CW Dou","year":"2022","unstructured":"Dou CW, Zhang CX, Liu J, Cheng J, Jin LM, Liu JW, Zhang CW (2022) Analysis for the short-term efficacy and long-term prognosis of laparoscopic and laparotomy radical resection for gallbladder cancer. Zhonghua Wai Ke Za Zhi 60:140\u2013147. https:\/\/doi.org\/10.3760\/cma.j.cn112139-20210226-00099","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"5975_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3892\/ijmm.2019.4317","volume":"44","author":"D Fang","year":"2019","unstructured":"Fang D, Peng J, Wang G, Zhou D, Geng X (2019) Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo. Int J Mol Med 44:1325\u20131332. https:\/\/doi.org\/10.3892\/ijmm.2019.4317","journal-title":"Int J Mol Med"},{"key":"5975_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/brv.12243","volume":"92","author":"YZ Foo","year":"2017","unstructured":"Foo YZ, Nakagawa S, Rhodes G, Simmons LW (2017) The effects of sex hormones on immune function: a meta-analysis. Biol Rev Camb Philos Soc 92:551\u2013571. https:\/\/doi.org\/10.1111\/brv.12243","journal-title":"Biol Rev Camb Philos Soc"},{"key":"5975_CR22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/j.1349-7006.2011.01981.x","volume":"102","author":"Q Gao","year":"2011","unstructured":"Gao Q, Wang X-Y, Qiu S-J, Zhou J, Shi Y-H, Zhang B-H, Fan J (2011) Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma. Cancer Sci 102:1522\u20131531. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01981.x","journal-title":"Cancer Sci"},{"key":"5975_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040778","author":"P Garc\u00eda","year":"2020","unstructured":"Garc\u00eda P et al (2020) Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040778","journal-title":"Cancers (Basel)"},{"key":"5975_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205055","author":"K Gera","year":"2023","unstructured":"Gera K et al (2023) Prognosis and treatment outcomes of bone metastasis in gallbladder adenocarcinoma: a SEER-based study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15205055","journal-title":"Cancers (Basel)"},{"key":"5975_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R (2018) Current understanding of the human microbiome. Nat Med 24:392\u2013400. https:\/\/doi.org\/10.1038\/nm.4517","journal-title":"Nat Med"},{"key":"5975_CR26","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO (2015) Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol 21:12211\u201312217. https:\/\/doi.org\/10.3748\/wjg.v21.i43.12211","journal-title":"World J Gastroenterol"},{"key":"5975_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00464-005-0121-x","volume":"20","author":"T Goetze","year":"2006","unstructured":"Goetze T, Paolucci V (2006) Does laparoscopy worsen the prognosis for incidental gallbladder cancer? Surg Endosc 20:286\u2013293","journal-title":"Surg Endosc"},{"key":"5975_CR28","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1158\/1078-0432.CCR-20-1310","volume":"26","author":"L Goyal","year":"2020","unstructured":"Goyal L et al (2020) Phase I and biomarker study of the Wnt pathway modulator DKN-01 in combination with gemcitabine\/cisplatin in advanced biliary tract cancer. Clin Cancer Res 26:6158\u20136167. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1310","journal-title":"Clin Cancer Res"},{"key":"5975_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883\u2013899. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"key":"5975_CR30","doi-asserted-by":"publisher","unstructured":"Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 edition) (2020) Zhonghua Wai Ke Za Zhi 58:243\u2013251 https:\/\/doi.org\/10.3760\/cma.j.cn112139-20200106-00014","DOI":"10.3760\/cma.j.cn112139-20200106-00014"},{"key":"5975_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/OTT.S346635","volume":"15","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang J, Liu X, Liu H, Zhang Y, Liu J (2022) Successful treatment of metastatic gallbladder carcinoma with PD-L1 expression by the combination of PD-1 inhibitor plus bevacizumab with chemotherapy: a case report. Onco Targets Ther 15:629\u2013636. https:\/\/doi.org\/10.2147\/OTT.S346635","journal-title":"Onco Targets Ther"},{"key":"5975_CR32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven DC, Erul E, Kaygusuz Y, Akagunduz B, Kilickap S, De Luca R, Rizzo A (2023) Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data. Support Care Cancer 31:624. https:\/\/doi.org\/10.1007\/s00520-023-08083-w","journal-title":"Support Care Cancer"},{"key":"5975_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.31729\/jnma.7923","volume":"61","author":"S Gyawali","year":"2023","unstructured":"Gyawali S, Pokhrel B, Sharma D, Bhatta NC, Kandel BP, Lakhey PJ (2023) Adenosquamous carcinoma of gallbladder with unusual prognosis: a case report. JNMA J Nepal Med Assoc 61:76\u201379. https:\/\/doi.org\/10.31729\/jnma.7923","journal-title":"JNMA J Nepal Med Assoc"},{"key":"5975_CR34","doi-asserted-by":"publisher","first-page":"13469","DOI":"10.2147\/CMAR.S286292","volume":"12","author":"S He","year":"2020","unstructured":"He S, Yu T, Khadaroo PA, Cai L, Chu Y, Wei F, Liang X (2020) A comparison between the prognosis of simultaneous and salvage radical resection in incidental gallbladder. Cancer Cancer Manag Res 12:13469\u201313478. https:\/\/doi.org\/10.2147\/CMAR.S286292","journal-title":"Cancer Cancer Manag Res"},{"key":"5975_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-024-04905-5","volume":"22","author":"X He","year":"2024","unstructured":"He X et al (2024) Correction to: increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer. J Transl Med 22:118. https:\/\/doi.org\/10.1186\/s12967-024-04905-5","journal-title":"J Transl Med"},{"key":"5975_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/cas.12096","volume":"104","author":"M Herrera","year":"2013","unstructured":"Herrera M et al (2013) Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci 104:437\u2013444. https:\/\/doi.org\/10.1111\/cas.12096","journal-title":"Cancer Sci"},{"key":"5975_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0039-6060(97)90185-9","volume":"121","author":"CA Jacobi","year":"1997","unstructured":"Jacobi CA, Sabat R, B\u00f6hm B, Zieren HU, Volk HD, M\u00fcller JM (1997) Pneumoperitoneum with carbon dioxide stimulates growth of malignant colonic cells. Surgery 121:72\u201378","journal-title":"Surgery"},{"key":"5975_CR38","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.3892\/ol.2018.9358","volume":"16","author":"L Jiang","year":"2018","unstructured":"Jiang L, Liu M, Cai X, Xie L, She F, Chen Y (2018) Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer. Oncol Lett 16:6065\u20136070. https:\/\/doi.org\/10.3892\/ol.2018.9358","journal-title":"Oncol Lett"},{"key":"5975_CR39","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s13277-013-1207-z","volume":"35","author":"K Jin","year":"2014","unstructured":"Jin K et al (2014) miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. Tumour Biol 35:1503\u20131510","journal-title":"Tumour Biol"},{"key":"5975_CR40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/1541-7786.MCR-12-0030","volume":"10","author":"A-C Johansson","year":"2012","unstructured":"Johansson A-C et al (2012) Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Mol Cancer Res 10:1158\u20131168","journal-title":"Mol Cancer Res"},{"key":"5975_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5009\/gnl15080","volume":"10","author":"W Jung","year":"2016","unstructured":"Jung W, Jang J-Y, Kang MJ, Chang YR, Shin YC, Chang J, Kim S-W (2016) Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with T2 gallbladder cancer. Gut Liver 10:140\u2013146. https:\/\/doi.org\/10.5009\/gnl15080","journal-title":"Gut Liver"},{"key":"5975_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/mco.2013.121","volume":"1","author":"K Kai","year":"2013","unstructured":"Kai K et al (2013) Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor. Mol Clin Oncol 1:633\u2013638","journal-title":"Mol Clin Oncol"},{"key":"5975_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"N Kamada","year":"2013","unstructured":"Kamada N, Seo S-U, Chen GY, N\u00fa\u00f1ez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321\u2013335. https:\/\/doi.org\/10.1038\/nri3430","journal-title":"Nat Rev Immunol"},{"key":"5975_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2739\/kurumemedj.MS65005","volume":"63","author":"R Kawahara","year":"2017","unstructured":"Kawahara R et al (2017) Evaluation of surgical procedures for T2 gallbladder cancer in terms of recurrence and prognosis. Kurume Med J 63:15\u201322. https:\/\/doi.org\/10.2739\/kurumemedj.MS65005","journal-title":"Kurume Med J"},{"key":"5975_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12957-023-03001-0","volume":"21","author":"Y Kihara","year":"2023","unstructured":"Kihara Y, Yokomizo H, Murotani K (2023) Impact of acute cholecystitis comorbidity on prognosis after surgery for gallbladder cancer: a propensity score analysis. World J Surg Oncol 21:109. https:\/\/doi.org\/10.1186\/s12957-023-03001-0","journal-title":"World J Surg Oncol"},{"key":"5975_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000132570","volume":"29","author":"JH Kim","year":"2008","unstructured":"Kim JH et al (2008) Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol 29:41\u201349. https:\/\/doi.org\/10.1159\/000132570","journal-title":"Tumour Biol"},{"key":"5975_CR47","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/jcp.2010.080713","volume":"63","author":"H Kim","year":"2010","unstructured":"Kim H et al (2010) Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. J Clin Pathol 63:1048\u20131053. https:\/\/doi.org\/10.1136\/jcp.2010.080713","journal-title":"J Clin Pathol"},{"key":"5975_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2020.01.026","volume":"130","author":"RD Kim","year":"2020","unstructured":"Kim RD et al (2020a) Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer. Eur J Cancer 130:219\u2013227. https:\/\/doi.org\/10.1016\/j.ejca.2020.01.026","journal-title":"Eur J Cancer"},{"key":"5975_CR49","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1002\/cncr.32964","volume":"126","author":"RD Kim","year":"2020","unstructured":"Kim RD et al (2020b) A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer. Cancer 126:3464\u20133470. https:\/\/doi.org\/10.1002\/cncr.32964","journal-title":"Cancer"},{"key":"5975_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/apm.13186","volume":"129","author":"JY Kim","year":"2021","unstructured":"Kim JY, Sung Y-N, Hong S-M (2021a) High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer. APMIS 129:729\u2013742. https:\/\/doi.org\/10.1111\/apm.13186","journal-title":"APMIS"},{"key":"5975_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051089","author":"M Kim","year":"2021","unstructured":"Kim M, Kim H, Han Y, Sohn H, Kang JS, Kwon W, Jang J-Y (2021b) Prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen 19\u20139 (CA 19\u20139) in gallbladder cancer; 65 IU\/mL of CA 19\u20139 Is the new cut-off value for prognosis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13051089","journal-title":"Cancers (Basel)"},{"key":"5975_CR52","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.1093\/oncolo\/oyae076","volume":"29","author":"Y Kim","year":"2024","unstructured":"Kim Y, Jee S, Kim H, Paik SS, Choi D, Yoo SH, Shin S-J (2024) EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance. Oncologist 29:e1051\u2013e1060. https:\/\/doi.org\/10.1093\/oncolo\/oyae076","journal-title":"Oncologist"},{"key":"5975_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12866-022-02557-3","volume":"22","author":"M Kirishima","year":"2022","unstructured":"Kirishima M et al (2022) Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis. BMC Microbiol 22:147. https:\/\/doi.org\/10.1186\/s12866-022-02557-3","journal-title":"BMC Microbiol"},{"key":"5975_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.048","author":"S Kitamoto","year":"2020","unstructured":"Kitamoto S et al (2020) The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.05.048","journal-title":"Cell"},{"key":"5975_CR55","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaoncol.2020.2814","volume":"6","author":"O Klein","year":"2020","unstructured":"Klein O et al (2020) Evaluation of combination nivolumab and ipilimumab immunotherapy in patients with advanced biliary tract cancers: subgroup analysis of a phase 2 nonrandomized clinical trial. JAMA Oncol 6:1405\u20131409. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2814","journal-title":"JAMA Oncol"},{"key":"5975_CR56","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.2147\/CMAR.S272116","volume":"13","author":"W Kong","year":"2021","unstructured":"Kong W, Zhang L, An R, Yang M, Wang H (2021) Diagnostic value of serum D-dimer for detection of gallbladder carcinoma. Cancer Manag Res 13:2549\u20132556. https:\/\/doi.org\/10.2147\/CMAR.S272116","journal-title":"Cancer Manag Res"},{"key":"5975_CR57","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1245\/s10434-014-4300-7","volume":"22","author":"H Lee","year":"2015","unstructured":"Lee H et al (2015) Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol 22:2779\u20132786. https:\/\/doi.org\/10.1245\/s10434-014-4300-7","journal-title":"Ann Surg Oncol"},{"key":"5975_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.surg.2017.05.004","volume":"162","author":"W Lee","year":"2017","unstructured":"Lee W et al (2017) Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study. Surgery 162:515\u2013524. https:\/\/doi.org\/10.1016\/j.surg.2017.05.004","journal-title":"Surgery"},{"key":"5975_CR59","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11605-019-04198-w","volume":"24","author":"EC Lee","year":"2020","unstructured":"Lee EC, Park S-J, Lee SD, Han S-S, Kim SH (2020) Effects of sarcopenia on prognosis after resection of gallbladder cancer. J Gastrointest Surg 24:1082\u20131091. https:\/\/doi.org\/10.1007\/s11605-019-04198-w","journal-title":"J Gastrointest Surg"},{"key":"5975_CR60","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1158\/1078-0432.CCR-21-3548","volume":"28","author":"S Lee","year":"2022","unstructured":"Lee S et al (2022) Phase II study of ramucirumab in advanced biliary tract cancer previously treated by gemcitabine-based chemotherapy. Clin Cancer Res 28:2229\u20132236. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3548","journal-title":"Clin Cancer Res"},{"key":"5975_CR61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(22)00335-1","volume":"8","author":"C-K Lee","year":"2023","unstructured":"Lee C-K et al (2023) Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean cancer study group (KCSG-HB19-14). Lancet Gastroenterol Hepatol 8:56\u201365. https:\/\/doi.org\/10.1016\/S2468-1253(22)00335-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5975_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12094-013-1063-8","volume":"16","author":"J Li","year":"2014","unstructured":"Li J et al (2014) PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer. Clin Transl Oncol 16:200\u2013207. https:\/\/doi.org\/10.1007\/s12094-013-1063-8","journal-title":"Clin Transl Oncol"},{"key":"5975_CR63","first-page":"703","volume":"36","author":"JM Li","year":"2015","unstructured":"Li JM, Shao JL, Zeng WJ, Liang RB (2015) General\/epidural anesthesia in combination preserves NK cell activity and affects cytokine response in cervical carcinoma patients undergoing radical resection: a cohort prospective study. Eur J Gynaecol Oncol 36:703\u2013707","journal-title":"Eur J Gynaecol Oncol"},{"key":"5975_CR64","doi-asserted-by":"publisher","first-page":"300060520946558","DOI":"10.1177\/0300060520946558","volume":"48","author":"J Li","year":"2020","unstructured":"Li J, Miao Y, Wang Y, Chen P, Lan J, Wu H (2020) Advanced primary squamous cell carcinoma of gallbladder and potential predictive biomarkers for prognosis. J Int Med Res 48:300060520946558. https:\/\/doi.org\/10.1177\/0300060520946558","journal-title":"J Int Med Res"},{"key":"5975_CR65","doi-asserted-by":"publisher","first-page":"33065","DOI":"10.18632\/oncotarget.5279","volume":"6","author":"SX Lian","year":"2015","unstructured":"Lian SX et al (2015) Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer. Oncotarget 6:33065\u201333076. https:\/\/doi.org\/10.18632\/oncotarget.5279","journal-title":"Oncotarget"},{"key":"5975_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11938","volume":"107","author":"F Liu","year":"2020","unstructured":"Liu F, Li F-Y (2020) Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg 107:e632. https:\/\/doi.org\/10.1002\/bjs.11938","journal-title":"Br J Surg"},{"key":"5975_CR67","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.3748\/wjg.v19.i31.5150","volume":"19","author":"G-J Liu","year":"2013","unstructured":"Liu G-J, Li X-H, Chen Y-X, Sun H-D, Zhao G-M, Hu S-Y (2013) Radical lymph node dissection and assessment: impact on gallbladder cancer prognosis. World J Gastroenterol 19:5150\u20135158. https:\/\/doi.org\/10.3748\/wjg.v19.i31.5150","journal-title":"World J Gastroenterol"},{"key":"5975_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.803454","volume":"12","author":"Q-Q Liu","year":"2022","unstructured":"Liu Q-Q, Lin H-M, Han H-W, Yang C-N, Liu C, Zhang R (2022) Complete response to combined chemotherapy and anti-PD-1 therapy for recurrent gallbladder carcinosarcoma: a case report and literature review. Front Oncol 12:803454. https:\/\/doi.org\/10.3389\/fonc.2022.803454","journal-title":"Front Oncol"},{"key":"5975_CR69","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.asjsur.2023.11.051","volume":"47","author":"F Liu","year":"2024","unstructured":"Liu F, Huang Q, Lin Y-X, Li F-Y (2024a) Re-operation for incidental gallbladder carcinoma: when is the optimal time interval? Asian J Surg 47:1246\u20131247. https:\/\/doi.org\/10.1016\/j.asjsur.2023.11.051","journal-title":"Asian J Surg"},{"key":"5975_CR70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12957-024-03436-z","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu F, Miao W, Nan J, Shi Z, Zhang A, Bo Y, Xu J (2024b) Clinical diagnosis and treatment of 37 cases of gallbladder neuroendocrine carcinoma. World J Surg Oncol 22:157. https:\/\/doi.org\/10.1186\/s12957-024-03436-z","journal-title":"World J Surg Oncol"},{"key":"5975_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00423-024-03247-6","volume":"409","author":"F Liu","year":"2024","unstructured":"Liu F, Wang J-K, Ma W-J, Hu H-J, Jin Y-W, Li F-Y (2024c) Prognostic value of combined preoperative inflammatory marker neutrophil-lymphocyte ratio and platelet distribution width in patients with gallbladder carcinoma Langenbecks. Arch Surg 409:51. https:\/\/doi.org\/10.1007\/s00423-024-03247-6","journal-title":"Arch Surg"},{"key":"5975_CR72","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002244","volume":"94","author":"W Lu","year":"2015","unstructured":"Lu W et al (2015) Down-regulated phosphoglycerate kinase 1 expression is associated with poor prognosis in patients with gallbladder cancer. Medicine (Baltimore) 94:e2244. https:\/\/doi.org\/10.1097\/MD.0000000000002244","journal-title":"Medicine (Baltimore)"},{"key":"5975_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00423-023-03199-3","volume":"409","author":"T-R Lv","year":"2023","unstructured":"Lv T-R, Liu F, Jin Y-W, Li F-Y (2023) Comparative analyses between radically re-resected incidental gallbladder carcinoma and primary radically resected gallbladder carcinoma: a single-center experience in China. Langenbecks Arch Surg 409:2. https:\/\/doi.org\/10.1007\/s00423-023-03199-3","journal-title":"Langenbecks Arch Surg"},{"key":"5975_CR74","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.biopha.2016.10.064","volume":"84","author":"F Ma","year":"2016","unstructured":"Ma F, Wang S-H, Cai Q, Zhang M-D, Yang Y, Ding J (2016) Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Biomed Pharmacother 84:1249\u20131255. https:\/\/doi.org\/10.1016\/j.biopha.2016.10.064","journal-title":"Biomed Pharmacother"},{"key":"5975_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216398","volume":"575","author":"Q Ma","year":"2023","unstructured":"Ma Q et al (2023) EMP3 as a key downstream target of miR-663a regulation interferes with MAPK\/ERK signaling pathway to inhibit gallbladder cancer progression. Cancer Lett 575:216398. https:\/\/doi.org\/10.1016\/j.canlet.2023.216398","journal-title":"Cancer Lett"},{"key":"5975_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.11.027","author":"F-X Meng","year":"2023","unstructured":"Meng F-X, Zhang J-X, Guo Y-R, Wang L-J, Zhang H-Z, Shao W-H, Xu J (2023) Contrast-enhanced CT-based deep learning radiomics nomogram for the survival prediction in gallbladder cancer postoperative. Acad Radiol. https:\/\/doi.org\/10.1016\/j.acra.2023.11.027","journal-title":"Acad Radiol"},{"issue":"Suppl 2","key":"5975_CR77","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.lungcan.2004.07.977","volume":"45","author":"P Micke","year":"2004","unstructured":"Micke P, Ostman A (2004) Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45(Suppl 2):S163\u2013S175","journal-title":"Lung Cancer"},{"key":"5975_CR78","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1016\/j.ejca.2014.09.013","volume":"50","author":"M Moehler","year":"2014","unstructured":"Moehler M et al (2014) Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme. Eur J Cancer 50:3125\u20133135. https:\/\/doi.org\/10.1016\/j.ejca.2014.09.013","journal-title":"Eur J Cancer"},{"key":"5975_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40168-019-0712-8","volume":"7","author":"N Molinero","year":"2019","unstructured":"Molinero N et al (2019) The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Microbiome 7:100. https:\/\/doi.org\/10.1186\/s40168-019-0712-8","journal-title":"Microbiome"},{"key":"5975_CR80","doi-asserted-by":"publisher","first-page":"485","DOI":"10.14701\/ahbps.2021.25.4.485","volume":"25","author":"HH Nag","year":"2021","unstructured":"Nag HH, Nekarakanti PK, Sachan A, Nabi P, Tyagi S (2021) Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: a matched case-control study. Ann Hepatobiliary Pancreat Surg 25:485\u2013491. https:\/\/doi.org\/10.14701\/ahbps.2021.25.4.485","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"5975_CR81","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00534-011-0439-9","volume":"19","author":"Y Nasu","year":"2012","unstructured":"Nasu Y et al (2012) The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 19:274\u2013280. https:\/\/doi.org\/10.1007\/s00534-011-0439-9","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"5975_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12032-014-0167-5","volume":"31","author":"J Nigam","year":"2014","unstructured":"Nigam J, Chandra A, Kazmi HR, Singh A, Gupta V, Parmar D, Srivastava MK (2014) Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study. Med Oncol 31:167. https:\/\/doi.org\/10.1007\/s12032-014-0167-5","journal-title":"Med Oncol"},{"key":"5975_CR83","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12957-023-03171-x","volume":"21","author":"LE Nooijen","year":"2023","unstructured":"Nooijen LE, Gustafsson-Liljefors M, Erdmann JI, D\u2019Souza MA, Gilg S, Villard C, Jansson H (2023) Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis. World J Surg Oncol 21:286. https:\/\/doi.org\/10.1186\/s12957-023-03171-x","journal-title":"World J Surg Oncol"},{"key":"5975_CR84","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-020-01742-4","volume":"39","author":"M-S Pan","year":"2020","unstructured":"Pan M-S, Wang H, Ansari KH, Li X-P, Sun W, Fan Y-Z (2020) Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway. J Exp Clin Cancer Res 39:234. https:\/\/doi.org\/10.1186\/s13046-020-01742-4","journal-title":"J Exp Clin Cancer Res"},{"key":"5975_CR85","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/MS9.0000000000000699","volume":"85","author":"N Pandit","year":"2023","unstructured":"Pandit N, Neupane D, Nalbo D, Bhattarai S, Deo KB, Jaiswal LS, Adhikary S (2023) Resectability and prognosis of gallbladder cancer: a cross-sectional study of 100 cases from a tertiary care centre of Eastern Nepal. Ann Med Surg (Lond) 85:1755\u20131760. https:\/\/doi.org\/10.1097\/MS9.0000000000000699","journal-title":"Ann Med Surg (Lond)"},{"key":"5975_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.peptides.2012.12.016","volume":"42","author":"K Pazaitou-Panayiotou","year":"2013","unstructured":"Pazaitou-Panayiotou K et al (2013) Gonadotropin-releasing hormone neuropeptides and receptor in human breast cancer: correlation to poor prognosis parameters. Peptides 42:15\u201324. https:\/\/doi.org\/10.1016\/j.peptides.2012.12.016","journal-title":"Peptides"},{"key":"5975_CR87","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457\u2013465. https:\/\/doi.org\/10.1038\/nrendo.2012.49","journal-title":"Nat Rev Endocrinol"},{"key":"5975_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00428-022-03482-6","volume":"482","author":"B Pehlivanoglu","year":"2023","unstructured":"Pehlivanoglu B et al (2023) Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis. Virchows Arch 482:311\u2013323. https:\/\/doi.org\/10.1007\/s00428-022-03482-6","journal-title":"Virchows Arch"},{"key":"5975_CR89","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s10620-013-2713-y","volume":"58","author":"CHC Pilgrim","year":"2013","unstructured":"Pilgrim CHC, Groeschl RT, Turaga KK, Gamblin TC (2013) Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci 58:2455\u20132462. https:\/\/doi.org\/10.1007\/s10620-013-2713-y","journal-title":"Dig Dis Sci"},{"key":"5975_CR90","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.7314\/APJCP.2012.13.3.1015","volume":"13","author":"K Qu","year":"2012","unstructured":"Qu K et al (2012) Prognosis and management for gallbladder cancer with hepatic invasion: long-term results of 139 patients from a single center in China. Asian Pac J Cancer Prev 13:1015\u20131018","journal-title":"Asian Pac J Cancer Prev"},{"key":"5975_CR91","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"5975_CR92","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/SLA.0000000000000628","volume":"261","author":"KW Reisinger","year":"2015","unstructured":"Reisinger KW et al (2015) Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 261:345\u2013352. https:\/\/doi.org\/10.1097\/SLA.0000000000000628","journal-title":"Ann Surg"},{"key":"5975_CR93","doi-asserted-by":"publisher","first-page":"107327482094804","DOI":"10.1177\/1073274820948047","volume":"27","author":"AD Ricci","year":"2020","unstructured":"Ricci AD, Rizzo A, Brandi G (2020) Immunotherapy in biliary tract cancer: worthy of a second look. Cancer Control 27:1073274820948047. https:\/\/doi.org\/10.1177\/1073274820948047","journal-title":"Cancer Control"},{"key":"5975_CR94","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A et al (2021) Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol 17:1455\u20131466. https:\/\/doi.org\/10.1080\/17425255.2021.2029405","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5975_CR95","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00262-023-03366-x","volume":"72","author":"A Rizzo","year":"2023","unstructured":"Rizzo A et al (2023) Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study. Cancer Immunol Immunother 72:1381\u20131394. https:\/\/doi.org\/10.1007\/s00262-023-03366-x","journal-title":"Cancer Immunol Immunother"},{"key":"5975_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101835","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Rizzo A, Aksoy S, Guven DC (2024) Prognostic significance of the royal marsden hospital (RMH) score in patients with cancer: a systematic review and meta-analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16101835","journal-title":"Cancers (Basel)"},{"key":"5975_CR97","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/archsurg.135.11.1340","volume":"135","author":"L Sarli","year":"2000","unstructured":"Sarli L, Contini S, Sansebastiano G, Gobbi S, Costi R, Roncoroni L (2000) Does laparoscopic cholecystectomy worsen the prognosis of unsuspected gallbladder cancer? Arch Surg 135:1340\u20131344","journal-title":"Arch Surg"},{"key":"5975_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.coph.2010.01.002","volume":"10","author":"K Schr\u00f6der","year":"2010","unstructured":"Schr\u00f6der K (2010) Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature. Curr Opin Pharmacol 10:122\u2013126. https:\/\/doi.org\/10.1016\/j.coph.2010.01.002","journal-title":"Curr Opin Pharmacol"},{"key":"5975_CR99","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jiph.2020.11.005","volume":"14","author":"N Serra","year":"2021","unstructured":"Serra N et al (2021) Human bile microbiota: a retrospective study focusing on age and gender. J Infect Public Health 14:206\u2013213. https:\/\/doi.org\/10.1016\/j.jiph.2020.11.005","journal-title":"J Infect Public Health"},{"key":"5975_CR100","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1007\/s00432-022-04428-w","volume":"149","author":"H Sheth","year":"2023","unstructured":"Sheth H, Limaye S, Kumar P, Shreenivas A (2023) Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review. J Cancer Res Clin Oncol 149:4915\u20134923. https:\/\/doi.org\/10.1007\/s00432-022-04428-w","journal-title":"J Cancer Res Clin Oncol"},{"key":"5975_CR101","first-page":"2015","volume":"7","author":"Z Shi","year":"2015","unstructured":"Shi Z et al (2015) Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell\/adenosquamous carcinoma of gallbladder. Am J Transl Res 7:2015\u20132025","journal-title":"Am J Transl Res"},{"key":"5975_CR102","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jso.25509","volume":"120","author":"M Sierzega","year":"2019","unstructured":"Sierzega M, Chrzan R, Wiktorowicz M, Kolodziejczyk P, Richter P (2019) Prognostic and predictive implications of sarcopenia in Western patients undergoing gastric resections for carcinoma of the stomach. J Surg Oncol 120:473\u2013482. https:\/\/doi.org\/10.1002\/jso.25509","journal-title":"J Surg Oncol"},{"key":"5975_CR103","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","volume":"14","author":"SR Sinha","year":"2022","unstructured":"Sinha SR, Prakash P, Singh RK, Sinha DK (2022) Assessment of tumor markers CA 19\u20139, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World J Gastrointest Surg 14:1272\u20131284. https:\/\/doi.org\/10.4240\/wjgs.v14.i11.1272","journal-title":"World J Gastrointest Surg"},{"key":"5975_CR104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10735-014-9597-9","volume":"46","author":"J Sun","year":"2015","unstructured":"Sun J et al (2015) ATP5b and \u03b22-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. J Mol Histol 46:57\u201365. https:\/\/doi.org\/10.1007\/s10735-014-9597-9","journal-title":"J Mol Histol"},{"key":"5975_CR105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/00325481.2024.2345585","volume":"136","author":"Y Sun","year":"2024","unstructured":"Sun Y, Gong J, Li Z, Han L, Sun D (2024) Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy. Postgrad Med 136:278\u2013291. https:\/\/doi.org\/10.1080\/00325481.2024.2345585","journal-title":"Postgrad Med"},{"key":"5975_CR106","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer J Clin"},{"key":"5975_CR107","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s004640000145","volume":"14","author":"K Suzuki","year":"2000","unstructured":"Suzuki K, Kimura T, Ogawa H (2000) Long-term prognosis of gallbladder cancer diagnosed after laparoscopic cholecystectomy. Surg Endosc 14:712\u2013716","journal-title":"Surg Endosc"},{"key":"5975_CR108","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034163","volume":"102","author":"X Tang","year":"2023","unstructured":"Tang X et al (2023) Effect of different lymph node dissection methods on the number of lymph nodes detected and prognosis in gallbladder cancer. Medicine (Baltimore) 102:e34163. https:\/\/doi.org\/10.1097\/MD.0000000000034163","journal-title":"Medicine (Baltimore)"},{"key":"5975_CR109","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1503\/cjs.019719","volume":"65","author":"S Tharmalingam","year":"2022","unstructured":"Tharmalingam S, Flemming J, Richardson H, Hurlbut D, Cleary S, Nanji S (2022) Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study. Can J Surg 65:E16\u2013E24. https:\/\/doi.org\/10.1503\/cjs.019719","journal-title":"Can J Surg"},{"key":"5975_CR110","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","volume":"261","author":"T Voron","year":"2015","unstructured":"Voron T et al (2015) Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 261:1173\u20131183. https:\/\/doi.org\/10.1097\/SLA.0000000000000743","journal-title":"Ann Surg"},{"key":"5975_CR111","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.2883","volume":"18","author":"S Walter","year":"2012","unstructured":"Walter S et al (2012) Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 18:1254\u20131261. https:\/\/doi.org\/10.1038\/nm.2883","journal-title":"Nat Med"},{"key":"5975_CR112","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","volume":"20","author":"Y-F Wang","year":"2014","unstructured":"Wang Y-F et al (2014) Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol 20:4085\u20134092. https:\/\/doi.org\/10.3748\/wjg.v20.i14.4085","journal-title":"World J Gastroenterol"},{"key":"5975_CR113","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/07357907.2016.1193745","volume":"34","author":"Q Wang","year":"2016","unstructured":"Wang Q et al (2016) SHP2 and UGP2 are biomarkers for progression and poor prognosis of gallbladder cancer. Cancer Invest 34:255\u2013264. https:\/\/doi.org\/10.1080\/07357907.2016.1193745","journal-title":"Cancer Invest"},{"key":"5975_CR114","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/jso.25085","volume":"117","author":"J Wang","year":"2018","unstructured":"Wang J, Liu J, Chang Q, Yang B, Li S, Gu C (2018) The association between preoperative serum interleukin-6 levels and postoperative prognosis in patients with T2 gallbladder cancer. J Surg Oncol 117:1672\u20131678. https:\/\/doi.org\/10.1002\/jso.25085","journal-title":"J Surg Oncol"},{"key":"5975_CR115","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3892\/or.2019.7249","volume":"42","author":"F-T Wang","year":"2019","unstructured":"Wang F-T, Hassan M, Ansari KH, Xu G-L, Li X-P, Fan Y-Z (2019) Upregulated NOX1 expression in gallbladder cancer-associated fibroblasts predicts a poor prognosis. Oncol Rep 42:1475\u20131486. https:\/\/doi.org\/10.3892\/or.2019.7249","journal-title":"Oncol Rep"},{"key":"5975_CR116","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejso.2019.10.015","volume":"46","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020a) Modified staging classification of gallbladder carcinoma on the basis of the 8th edition of the American Joint commission on cancer (AJCC) staging system. Eur J Surg Oncol 46:527\u2013533. https:\/\/doi.org\/10.1016\/j.ejso.2019.10.015","journal-title":"Eur J Surg Oncol"},{"key":"5975_CR117","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/cas.14239","volume":"111","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020b) Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer. Cancer Sci 111:219\u2013228. https:\/\/doi.org\/10.1111\/cas.14239","journal-title":"Cancer Sci"},{"key":"5975_CR118","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13578-024-01290-w","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang W, Huang C, Zhang L, Yu L, Liu Y, Wang P, Xia R (2024a) MST1R-targeted therapy in the battle against gallbladder cancer. Cell Biosci 14:109. https:\/\/doi.org\/10.1186\/s13578-024-01290-w","journal-title":"Cell Biosci"},{"key":"5975_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108047","volume":"50","author":"Y Wang","year":"2024","unstructured":"Wang Y, Kong Y, Yang Q, Zhong C, Zhou D, Wang W (2024b) Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: an updated retrospective cohort analysis. Eur J Surg Oncol 50:108047. https:\/\/doi.org\/10.1016\/j.ejso.2024.108047","journal-title":"Eur J Surg Oncol"},{"key":"5975_CR120","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41416-021-01583-8","volume":"126","author":"RC Wheatley","year":"2022","unstructured":"Wheatley RC, Kilgour E, Jacobs T, Lamarca A, Hubner RA, Valle JW, McNamara MG (2022) Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy. Br J Cancer 126:693\u2013705. https:\/\/doi.org\/10.1038\/s41416-021-01583-8","journal-title":"Br J Cancer"},{"key":"5975_CR121","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/ajco.13308","volume":"16","author":"X Wu","year":"2020","unstructured":"Wu X, Li B, Zheng C, Liu W, Hong T, He X (2020) Incidental gallbladder cancer after laparoscopic cholecystectomy: incidence, management, and prognosis. Asia Pac J Clin Oncol 16:158\u2013164. https:\/\/doi.org\/10.1111\/ajco.13308","journal-title":"Asia Pac J Clin Oncol"},{"key":"5975_CR122","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.4240\/wjgs.v15.i11.2413","volume":"15","author":"J-X Wu","year":"2023","unstructured":"Wu J-X, Hua R, Luo X-J, Xie F, Yao L (2023a) Effects of cytoreductive surgery combined with hyperthermic perfusion chemotherapy on prognosis of patients with advanced gallbladder cancer. World J Gastrointest Surg 15:2413\u20132422. https:\/\/doi.org\/10.4240\/wjgs.v15.i11.2413","journal-title":"World J Gastrointest Surg"},{"key":"5975_CR123","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.7150\/jca.83356","volume":"14","author":"Z Wu","year":"2023","unstructured":"Wu Z et al (2023b) APEX1 predicts poor prognosis of gallbladder cancer and affects biological properties of CD133+ GBC-SD cells via upregulating Jagged1. J Cancer 14:1443\u20131457. https:\/\/doi.org\/10.7150\/jca.83356","journal-title":"J Cancer"},{"key":"5975_CR124","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00464-001-9085-7","volume":"16","author":"C Wullstein","year":"2002","unstructured":"Wullstein C, Woeste G, Barkhausen S, Gross E, Hopt UT (2002) Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg Endosc 16:828\u2013832","journal-title":"Surg Endosc"},{"key":"5975_CR125","doi-asserted-by":"publisher","first-page":"738","DOI":"10.21037\/atm.2019.11.112","volume":"7","author":"Z Xiao","year":"2019","unstructured":"Xiao Z et al (2019) A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med 7:738. https:\/\/doi.org\/10.21037\/atm.2019.11.112","journal-title":"Ann Transl Med"},{"key":"5975_CR126","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.7314\/APJCP.2015.16.15.6255","volume":"16","author":"X-S Xu","year":"2015","unstructured":"Xu X-S, Miao R-C, Zhang L-Q, Wang R-T, Qu K, Pang Q, Liu C (2015) Model based on alkaline phosphatase and gamma-glutamyltransferase for gallbladder cancer prognosis. Asian Pac J Cancer Prev 16:6255\u20136259","journal-title":"Asian Pac J Cancer Prev"},{"key":"5975_CR127","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s13277-015-3929-6","volume":"37","author":"A Yadav","year":"2016","unstructured":"Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, Mittal B (2016) Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumour Biol 37:1835\u20131844. https:\/\/doi.org\/10.1007\/s13277-015-3929-6","journal-title":"Tumour Biol"},{"key":"5975_CR128","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10528-018-9843-z","volume":"56","author":"S Yadav","year":"2018","unstructured":"Yadav S, Chandra A, Kumar A, Mittal B (2018) Association of TERT-CLPTM1L and 8q24 Common genetic variants with gallbladder cancer susceptibility and prognosis in north Indian population. Biochem Genet 56:267\u2013282. https:\/\/doi.org\/10.1007\/s10528-018-9843-z","journal-title":"Biochem Genet"},{"key":"5975_CR129","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1155\/2013\/187043","volume":"35","author":"Z-l Yang","year":"2013","unstructured":"Yang Z-l et al (2013) Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer. Dis Markers 35:163\u2013172. https:\/\/doi.org\/10.1155\/2013\/187043","journal-title":"Dis Markers"},{"key":"5975_CR130","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1038\/s41598-022-13430-8","volume":"12","author":"G Yang","year":"2022","unstructured":"Yang G, Lu Z, Meng F, Wan Y, Zhang L, Xu Q, Wang Z (2022) Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer. Sci Rep 12:10072","journal-title":"Sci Rep"},{"key":"5975_CR131","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12957-023-03198-0","volume":"21","author":"J Yang","year":"2023","unstructured":"Yang J, Lv L, Zhao F, Mei X, Zhou H, Yu F (2023) The value of the preoperative Naples prognostic score in predicting prognosis in gallbladder cancer surgery patients. World J Surg Oncol 21:303. https:\/\/doi.org\/10.1186\/s12957-023-03198-0","journal-title":"World J Surg Oncol"},{"key":"5975_CR132","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1089\/lap.2018.0690","volume":"29","author":"L-H Yu","year":"2019","unstructured":"Yu L-H, Yuan B, Fu X-H, Yu W-L, Liu J, Zhang Y-J (2019) Does anatomic resection get more benefits than wedge hepatectomy on the prognosis for pT3 unsuspected gallbladder cancer? J Laparoendosc Adv Surg Tech A 29:1414\u20131418. https:\/\/doi.org\/10.1089\/lap.2018.0690","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"5975_CR133","first-page":"187","volume":"140","author":"M Zen","year":"2010","unstructured":"Zen M et al (2010) Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly 140:187\u2013201","journal-title":"Swiss Med Wkly"},{"key":"5975_CR134","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.29227","volume":"136","author":"H Zeng","year":"2015","unstructured":"Zeng H et al (2015) Cancer survival in China, 2003\u20132005: a population-based study. Int J Cancer 136:1921\u20131930. https:\/\/doi.org\/10.1002\/ijc.29227","journal-title":"Int J Cancer"},{"key":"5975_CR135","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12094-015-1310-2","volume":"17","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Jiang C, Li J, Sun J, Qu X (2015) Prognostic significance of preoperative neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in patients with gallbladder carcinoma. Clin Transl Oncol 17:810\u2013818. https:\/\/doi.org\/10.1007\/s12094-015-1310-2","journal-title":"Clin Transl Oncol"},{"key":"5975_CR136","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10620-018-5103-7","volume":"63","author":"W Zhang","year":"2018","unstructured":"Zhang W, Hong HJ, Chen Y-L (2018) Establishment of a gallbladder cancer-specific survival model to predict prognosis in non-metastatic gallbladder cancer patients after surgical resection. Dig Dis Sci 63:2251\u20132258. https:\/\/doi.org\/10.1007\/s10620-018-5103-7","journal-title":"Dig Dis Sci"},{"key":"5975_CR137","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3760\/cma.j.issn.0529-5815.2019.04.004","volume":"57","author":"D Zhang","year":"2019","unstructured":"Zhang D et al (2019) Pilot study of the relationship between clinical classification of gallbladder cancer and prognosis: a retrospective multicenter clinical study. Zhonghua Wai Ke Za Zhi 57:258\u2013264. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5815.2019.04.004","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"5975_CR138","doi-asserted-by":"publisher","first-page":"1144371","DOI":"10.3389\/fimmu.2023.1144371","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Case report: preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: a report of five cases and a literature review. Front Immunol 14:1144371. https:\/\/doi.org\/10.3389\/fimmu.2023.1144371","journal-title":"Front Immunol"},{"key":"5975_CR139","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-255403","author":"S Zhang","year":"2023","unstructured":"Zhang S, Nie J, Tai S, Zheng T (2023) PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2023-255403","journal-title":"BMJ Case Rep"},{"key":"5975_CR140","first-page":"568","volume":"98","author":"J Zhao","year":"2015","unstructured":"Zhao J, Mo H (2015) The impact of different anesthesia methods on stress reaction and immune function of the patients with gastric cancer during peri-operative period. J Med Assoc Thai 98:568\u2013573","journal-title":"J Med Assoc Thai"},{"key":"5975_CR141","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.21037\/tcr-22-123","volume":"11","author":"C Zheng","year":"2022","unstructured":"Zheng C et al (2022) Nomogram based on intramuscular adipose tissue content for predicting the prognosis of patients with gallbladder cancer after radical resection. Transl Cancer Res 11:1898\u20131908. https:\/\/doi.org\/10.21037\/tcr-22-123","journal-title":"Transl Cancer Res"},{"key":"5975_CR142","doi-asserted-by":"publisher","first-page":"7848","DOI":"10.3892\/mmr.2017.7520","volume":"16","author":"N Zhou","year":"2017","unstructured":"Zhou N, Cheng W, Peng C, Liu Y, Jiang B (2017) Decreased expression of hsa-miR-372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1. Mol Med Rep 16:7848\u20137854. https:\/\/doi.org\/10.3892\/mmr.2017.7520","journal-title":"Mol Med Rep"},{"key":"5975_CR143","doi-asserted-by":"publisher","first-page":"1171837","DOI":"10.3389\/fonc.2023.1171837","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen S, Wu Y, Li L, Lou Q, Chen Y, Xu S (2023) Multi-clinical index classifier combined with AI algorithm model to predict the prognosis of gallbladder cancer Front. Oncol 13:1171837. https:\/\/doi.org\/10.3389\/fonc.2023.1171837","journal-title":"Oncol"},{"key":"5975_CR144","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006137","volume":"96","author":"J Zhu","year":"2017","unstructured":"Zhu J, Zhang X-R, Yang H (2017) Effects of combined epidural and general anesthesia on intraoperative hemodynamic responses, postoperative cellular immunity, and prognosis in patients with gallbladder cancer: a randomized controlled trial. Medicine (Baltimore) 96:e6137. https:\/\/doi.org\/10.1097\/MD.0000000000006137","journal-title":"Medicine (Baltimore)"},{"key":"5975_CR145","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41389-021-00330-1","volume":"10","author":"D Zhu","year":"2021","unstructured":"Zhu D, Gu X, Lin Z, Yu D, Wang J (2021) High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis. Oncogenesis 10:43. https:\/\/doi.org\/10.1038\/s41389-021-00330-1","journal-title":"Oncogenesis"},{"key":"5975_CR146","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s40001-023-01299-w","volume":"28","author":"Y Zhu","year":"2023","unstructured":"Zhu Y et al (2023) Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database. Eur J Med Res 28:310. https:\/\/doi.org\/10.1186\/s40001-023-01299-w","journal-title":"Eur J Med Res"},{"key":"5975_CR147","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aar6918","volume":"359","author":"L Zitvogel","year":"2018","unstructured":"Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF (2018) The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science 359:1366\u20131370. https:\/\/doi.org\/10.1126\/science.aar6918","journal-title":"Science"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05975-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:03:36Z","timestamp":1730811816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05975-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,6]]},"references-count":147,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5975"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05975-0","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,6]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"447"}}